Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
PharmaBiome AG logo — Pioneering the development of microbiome-based therapies usi...

PharmaBiome AG

Pioneering the development of microbiome-based therapies using proprietary tools for their design and production.

Founded 2015 Switzerland Zurich, Switzerland 11 employees Convertible Note Total: $1.98M Biotechnology, Health Care

General Information

Company Name PharmaBiome AG
Founded Year 2015
Location Switzerland Zurich, Switzerland +1
Founders / Decision Makers
Team member
Employees 11
Industries Biotechnology, Health Care
Funding Stage Convertible Note
Social

Get notified when PharmaBiome AG moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About PharmaBiome AG

PharmaBiome AG is a Swiss-based startup that is pioneering the development of microbiome-based therapies using proprietary tools for their design and production. Founded in 2015 as a spin-off from ETH Zurich, the company has created a first-in-the-industry, patent-protected technology platform for the production of standardized microbiome-based products. Situated at the intersection of microbiology, biotechnology, and data science, PharmaBiome is focused on developing the biotechnology necessary to produce solutions compliant with the safety, efficacy, and trial requirements of human medicine. The company has invested significant time in developing a biology-based analysis tool that allows for the identification and selection of the metabolic functions essential to restore the gut microbiome to a balanced state. PharmaBiome has been recognized with several startup awards, including Venture Kick, the ETH Spark Award, and the BaseLaunch Accelerator. Its most recent investment was a Fr.1.75M Convertible Note investment on 08 July 2020. PharmaBiome's innovative approach holds promise in creating personalized treatments for patients with chronic inflammatory diseases, immune conditions, and special nutritional needs. The flexibility and speed of their production process provide a unique advantage in creating effective treatment options. With its focus on addressing disturbances of the gut microbiome, PharmaBiome AG stands at the forefront of advancing microbiome-based therapies.

Taxonomy: Microbiome-based Therapies, Biotherapeutics, Microbiology, Patent-Protected Technology, Start-up Awards, Intestinal Microbes, Gut Microbiome, Chronic Inflammatory Diseases, Immune Conditions, Nutritional Therapy, Biological Analysis, Clinical Translation, Function-Based Therapies

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note •••••• - 08 Jul 2020
Seed Round •••••• 1
Investor
21 Jan 2020
Grant •••••• 1 •••• •••• 01 Apr 2018
Pre Seed Round •••••• 1
Investor
14 Jun 2016
Grant •••••• 1
Investor
28 Apr 2016

View All 6 Funding Rounds

PharmaBiome AG Alternatives & Competitors

PharmaBiome AG vs
Ritter Pharmaceuticals
Ritter Pharmaceuticals

Pioneering the future of gut health with novel microbiome modulators for impactful patient outcomes.

Post Ipo Equity
Biotechnology, Health Care
PharmaBiome AG vs
REM Analytics
REM Analytics Switzerland

REM Analytics measures the microtype of people for the microbiome industry to improve product impact...

Unknown
4 employees
Analytics, Biotechnology
PharmaBiome AG vs
LISCure Biosciences Inc.
LISCure Biosciences Inc. Korea South

Live Biotherapeutics Immunotherapeutic Drugs

Series B
6 employees
Biotechnology, Health Care

FAQ About PharmaBiome AG

Pioneering the development of microbiome-based therapies using proprietary tools for their design and production.
PharmaBiome AG was founded in 2015.
PharmaBiome AG is headquartered in Zurich, Switzerland.
PharmaBiome AG operates in the following industries: Biotechnology, Health Care.
PharmaBiome AG has approximately 11 employees.
PharmaBiome AG has completed 6 funding rounds, raising a total of $1.98M. The latest funding stage is Convertible Note.
Top alternatives and competitors to PharmaBiome AG include Ritter Pharmaceuticals, REM Analytics, LISCure Biosciences Inc., SymbioPharm GmbH, Concerto Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PharmaBiome AG and Ritter Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors PharmaBiome AG and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy